US Patent Issued to Deciphera Pharmaceuticals on Sept. 16 for "Anti-viral activity of VPS34 inhibitors" (Massachusetts Inventor)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,955, issued on Sept. 16, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.).

"Anti-viral activity of VPS34 inhibitors" was invented by Daniel L. Flynn (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein, in part, are methods of treating viral infections, such as coronavirus infections, in patients in need thereof, comprising administering to the patients a VPS34 inhibitor."

The patent was filed on Nov. 24, 2021, under Application No. 17/534,795.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FP...